Earnings
NTEC
4.460
-2.19%
-0.100
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2017-12-31
53.32M
1.82M
--
--
--
--
1.13M
--
--
--
--
69.00K
56.34M
8.21M
--
--
--
--
--
--
--
8.21M
64.55M
--
1.85M
0.00
--
--
--
3.89M
--
--
--
--
--
--
5.75M
0.00
--
--
--
0.00
0.00
5.75M
727.00K
148.97M
-90.52M
--
--
--
58.80M
58.80M
64.55M
FY 2016-12-31
16.38M
1.85M
--
2.38M
--
--
2.38M
--
--
--
--
62.00K
20.67M
4.05M
--
--
--
--
--
--
--
4.05M
24.72M
--
1.15M
0.00
--
--
--
768.00K
--
--
--
--
--
--
1.92M
0.00
--
--
--
97.00K
97.00K
2.02M
727.00K
84.98M
-62.63M
--
--
--
22.70M
22.70M
24.72M
FY 2015-12-31
23.65M
7.02M
--
--
--
--
0.00
--
--
--
2.36M
62.00K
33.10M
4.08M
--
--
--
--
--
--
--
4.08M
37.17M
--
614.00K
0.00
--
--
--
701.00K
--
--
--
--
--
--
1.31M
0.00
--
--
--
327.00K
327.00K
1.64M
727.00K
84.98M
-49.80M
--
--
--
35.53M
35.53M
37.17M
FY 2014-12-31
6.24M
2.19M
--
283.99K
--
--
286.06K
--
--
--
27.74K
81.81K
8.83M
4.79M
--
--
--
--
--
--
0.00
4.79M
13.62M
--
200.60K
0.00
--
--
--
--
--
604.06K
--
--
--
1.22M
2.02M
0.00
--
--
--
1.27M
1.27M
3.29M
756.75K
55.63M
-46.06M
--
--
--
10.33M
10.33M
13.62M
FY 2013-12-31
3.30M
5.01M
--
517.91K
--
--
521.69K
--
--
--
202.01K
14.01K
9.04M
4.20M
--
--
--
--
--
--
58.84K
4.26M
13.30M
--
370.67K
0.00
--
--
--
--
--
658.97K
--
--
--
349.66K
1.38M
0.00
--
--
--
2.89M
2.89M
4.26M
638.24K
47.20M
-38.80M
--
--
--
9.04M
9.04M
13.30M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out NTEC latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Intec Pharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.